Stock Events

Baxter International 

$42.01
204
-$0.22-0.52% Thursday 21:00

Statistics

Day High
42.13
Day Low
41.25
52W High
49.47
52W Low
30.76
Volume
4,112,382
Avg. Volume
3,881,782
Mkt Cap
21.33B
P/E Ratio
8
Dividend Yield
2.76%
Dividend
1.16

Upcoming

Dividends

2.76%Dividend Yield
Jan 24
$0.29
Oct 23
$0.29
Jul 23
$0.29
Apr 23
$0.29
Jan 23
$0.29

Earnings

25AprExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Next
0.49
0.64
0.79
0.94
Expected EPS
0.62
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BAX. It's not an investment recommendation.

Analyst Ratings

45.67$Average Price Target
The highest estimate is $54.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Show more...
CEO
Jose Almeida
Employees
50000
Country
US
ISIN
US0718131099
WKN
000853815

Listings